Biomolecular condensates, membrane-less entities arising from liquid–liquid phase
separation, hold dichotomous roles in health and disease. Alongside their physiological …

Background. Aducanumab, a new monoclonal antibody that targets β‐amyloid aggregates,
has been granted conditional approval by the US FDA for treatment of mild Alzheimer's …

Background: Alzheimer's disease (AD) is a complex and severe neurodegenerative disease
that still lacks effective methods of diagnosis. The current diagnostic methods of AD rely on …

Citrus fruits exhibit a high level of different phytoconstituents, of which the changes in the
different parts of the fruit during ripening have not been thoroughly studied yet. Thus, in this …

The need to identify effective therapies for the treatment of psychiatric disorders is a
particularly important issue in modern societies. In addition, difficulties in finding new drugs …

Introduction Alzheimer's disease (AD) is a progressive neurodegenerative disorder. Current
core cerebrospinal fluid (CSF) AD biomarkers, widely employed for diagnosis, require a …

Dementia remains an extremely prevalent syndrome among older people and represents a
major cause of disability and dependency. Alzheimer's disease (AD) accounts for the …

Hydrazine-related chemicals (HRCs) with carcinogenic and neurotoxic potential are found in
certain mushrooms and plants used for food and in products employed in various industries …

Our understanding of Alzheimer's disease (AD) pathogenesis has developed with several
hypotheses over the last 40 years, including the Amyloid and Tau hypotheses. More …

We aim to systematically review and meta-analyze the effectiveness and safety of
psychedelics [psilocybin, ayahuasca (active component DMT), LSD and MDMA] in treating …